ASX - By Stock
|
PAA Biotech |
Re:
2023 , MND, K9 Cancer Commercial Deal , Covid , Human Cancer, OHD
|
|
Densy
|
153 |
43K |
15 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
153
|
43K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Densy
|
1.4K |
384K |
6 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
1.4K
|
384K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Densy
|
1.4K |
384K |
8 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
1.4K
|
384K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: First Patient Dosed in MND Phase 1/2 Trial
|
|
Densy
|
171 |
45K |
20 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
171
|
45K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Densy
|
1.4K |
384K |
12 |
19/11/22 |
19/11/22 |
ASX - By Stock
|
1.4K
|
384K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: First Patient Dosed in MND Phase 1/2 Trial
|
|
Densy
|
171 |
45K |
6 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
171
|
45K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: First Patient Dosed in MND Phase 1/2 Trial
|
|
Densy
|
171 |
45K |
16 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
171
|
45K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: First Patient Dosed in MND Phase 1/2 Trial
|
|
Densy
|
171 |
45K |
20 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
171
|
45K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Densy
|
207 |
49K |
10 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
207
|
49K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: First Patient Dosed in MND Phase 1/2 Trial
|
|
Densy
|
171 |
45K |
7 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
171
|
45K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: First Patient Dosed in MND Phase 1/2 Trial
|
|
Densy
|
171 |
45K |
23 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
171
|
45K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Densy
|
207 |
49K |
16 |
13/11/22 |
13/11/22 |
ASX - By Stock
|
207
|
49K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Densy
|
207 |
49K |
13 |
12/11/22 |
12/11/22 |
ASX - By Stock
|
207
|
49K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Densy
|
207 |
49K |
4 |
12/11/22 |
12/11/22 |
ASX - By Stock
|
207
|
49K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Densy
|
207 |
49K |
22 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
207
|
49K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Densy
|
207 |
49K |
16 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
207
|
49K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Densy
|
207 |
49K |
20 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
207
|
49K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Densy
|
207 |
49K |
18 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
207
|
49K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Densy
|
207 |
49K |
8 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
207
|
49K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Densy
|
207 |
49K |
9 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
207
|
49K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Densy
|
207 |
49K |
26 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
207
|
49K
|
26
|
|
ASX - By Stock
|
PAA Biotech |
Re:
AGM Questions 2022
|
|
Densy
|
78 |
17K |
16 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
78
|
17K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem webinar presentation
|
|
Densy
|
32 |
7.6K |
9 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
32
|
7.6K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem webinar presentation
|
|
Densy
|
32 |
7.6K |
4 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
32
|
7.6K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem webinar presentation
|
|
Densy
|
32 |
7.6K |
0 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
32
|
7.6K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem webinar presentation
|
|
Densy
|
32 |
7.6K |
7 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
32
|
7.6K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor Webinar
|
|
Densy
|
42 |
8.2K |
13 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
42
|
8.2K
|
13
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Densy
|
31 |
9.5K |
7 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
31
|
9.5K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor Webinar
|
|
Densy
|
42 |
8.2K |
10 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
42
|
8.2K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Densy
|
41 |
9.8K |
7 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
41
|
9.8K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Densy
|
41 |
9.8K |
6 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
41
|
9.8K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Densy
|
41 |
9.8K |
4 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
41
|
9.8K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Densy
|
41 |
9.8K |
3 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
41
|
9.8K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Densy
|
41 |
9.8K |
14 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
41
|
9.8K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Densy
|
41 |
9.8K |
3 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
41
|
9.8K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Densy
|
41 |
9.8K |
5 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
41
|
9.8K
|
5
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Densy
|
31 |
9.5K |
4 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
31
|
9.5K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Densy
|
41 |
9.8K |
19 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
41
|
9.8K
|
19
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Densy
|
31 |
9.5K |
8 |
30/10/22 |
30/10/22 |
ASX - By Stock
|
31
|
9.5K
|
8
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Densy
|
31 |
9.5K |
3 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
31
|
9.5K
|
3
|
|
ASX - By Stock
|
SMN |
Re:
I will wait to see both sides story before casting
|
|
Densy
|
564 |
148K |
5 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
564
|
148K
|
5
|
|
ASX - By Stock
|
SMN |
Re:
I will wait to see both sides story before casting
|
|
Densy
|
564 |
148K |
4 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
564
|
148K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Update on PharmAust Canine Cancer Trials
|
|
Densy
|
216 |
49K |
15 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
216
|
49K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Update on PharmAust Canine Cancer Trials
|
|
Densy
|
216 |
49K |
19 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
216
|
49K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Update on PharmAust Canine Cancer Trials
|
|
Densy
|
216 |
49K |
9 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
216
|
49K
|
9
|
|
ASX - By Stock
|
IBX |
Re:
[VIDEO] Imagion Biosystems (ASX:IBX) finds that diagnostic tech has potential to work on multiple cancers
|
|
Densy
|
79 |
37K |
7 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
79
|
37K
|
7
|
|
ASX - By Stock
|
IBX |
Re:
[VIDEO] Imagion Biosystems (ASX:IBX) finds that diagnostic tech has potential to work on multiple cancers
|
|
Densy
|
79 |
37K |
9 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
79
|
37K
|
9
|
|
ASX - By Stock
|
IBX |
Re:
[VIDEO] Imagion Biosystems (ASX:IBX) finds that diagnostic tech has potential to work on multiple cancers
|
|
Densy
|
79 |
37K |
6 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
79
|
37K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Densy
|
1.4K |
384K |
9 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
1.4K
|
384K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Densy
|
1.4K |
384K |
10 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
1.4K
|
384K
|
10
|
|